Mixed lineage kinase (MLK) controls tumor development and angiogenesis.

Saved in:
Bibliographic Details
Title: Mixed lineage kinase (MLK) controls tumor development and angiogenesis.
Authors: Kant S; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. skant1@bwh.harvard.edu., Caliz AD; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Yoo HJ; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Kaur G; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Learnard H; Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Khalil HA; Division of Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Davis RJ; Program of Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Keaney JFJ; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Source: Angiogenesis [Angiogenesis] 2025 May 02; Vol. 28 (3), pp. 29. Date of Electronic Publication: 2025 May 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 9814575 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7209 (Electronic) Linking ISSN: 09696970 NLM ISO Abbreviation: Angiogenesis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7209
DOI:10.1007/s10456-025-09978-4